Covis Pharma B.V.
Covis Pharma B.V., headquartered in the Netherlands, is a prominent player in the pharmaceutical industry, specialising in the development and commercialisation of innovative therapies for patients with respiratory and cardiovascular conditions. Founded in 2015, Covis Pharma has rapidly established itself as a trusted provider of essential medications, focusing on areas such as asthma, chronic obstructive pulmonary disease (COPD), and hypertension. With a commitment to improving patient outcomes, Covis Pharma offers a range of unique products that address unmet medical needs. The company’s strategic approach to drug development and its robust portfolio have positioned it as a key competitor in the global market. Notable achievements include successful partnerships and a growing presence in major operational regions across Europe and North America, reinforcing its dedication to enhancing healthcare solutions worldwide.
DitchCarbon Score
How does Covis Pharma B.V.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Real Estate Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Covis Pharma B.V.'s score of 23 is lower than 67% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Covis Pharma B.V.'s reported carbon emissions
Covis Pharma B.V., headquartered in the Netherlands, currently does not have publicly available carbon emissions data or specific reduction targets. Without emissions figures, it is challenging to assess their carbon footprint or the scope of their emissions (Scope 1, 2, or 3). However, the company is likely aware of the growing importance of climate commitments within the pharmaceutical industry. As such, it may be engaging in initiatives aimed at reducing its environmental impact, although specific details on these initiatives or any climate pledges have not been disclosed.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Covis Pharma B.V. is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
